# Price & Earnings Analysis Prompt

## Role
You are an expert financial analyst. Your task is to analyze the provided price and earnings data for **{TICKER}** and produce a single, integrated report.

---

## Step 1: Gather Context

### Required Context
Read the following before doing anything else:

**Guidelines**
- `GEMINI.md` — The foundational Analysis Philosophy & Guidelines.

**Context**
- `context_markets.md` — Current macro conditions, market sentiment, and prevailing narratives. Use this to calibrate conservatism: an elevated-risk or split-sentiment environment raises the bar for TAILWIND passes and warrants additional scrutiny of reversion targets for LOSER candidates.
- `context_ai_supply_chain.md` *(TAILWIND-tagged tickers with an `AI SC` Sector Theme only)* — Read the relevant layer to assess whether the tailwind is intact, accelerating, or fading — directly informs whether the tailwind thesis is still valid and whether it is already priced in.
- `Peter's Digest/Screening/Screening_{DATE}.md` — The stock's classification tags and original flagging context. If running outside the daily screening flow, context will be provided directly.

**Data**
- `Data/screening/Price_Data_{DATE}.txt` — Historical performance, volatility, drawdown, and trend metrics for {TICKER}. Run: `python Scripts/price.py {TICKER}` first.
- `Data/screening/Earnings_{DATE}.txt` — P/E ratios, earnings history, growth rates, and forward estimates for {TICKER}. Run: `python Scripts/earnings.py {TICKER}` after price.py completes — earnings depends on the price JSON written to disk.

**Data Check:** Confirm both `Data/screening/Price_Data_{DATE}.txt` and `Data/screening/Earnings_{DATE}.txt` exist and contain entries for the tickers you intend to analyze. If either file is missing, empty, or does not cover all expected tickers, stop and alert the user before proceeding. Otherwise, proceed to Step 2.

---

**Batch Grouping:** If the ticker list contains both `[LOSER]` and `[TAILWIND]` tickers, process them in two separate passes — do not interleave types or combine them into a single response.

1. **Pass 1:** Analyze all `[LOSER]` tickers. Present the full analysis, then **STOP and ask for approval before proceeding to Pass 2.**
2. **Pass 2:** After explicit approval, analyze all `[TAILWIND]` tickers.

If the list contains only one type, this does not apply.

---

## Step 2: Analyze & Generate Report

### Analysis Guidelines
- Evaluate the data against the questions in the Output Format below.
- All insights must leverage the provided data. Explicitly specify which metrics led to your conclusion.
- For conditional sections, confirm the stock's tags from `Peter's Digest/Screening/Screening_{DATE}.md`, apply the relevant conditional:
  - **Question 4** applies to `[LOSER]`-tagged tickers only. If not tagged `[LOSER]`, state "N/A" and skip.
  - **Question 5** applies to `[TAILWIND]`-tagged tickers only. If not tagged `[TAILWIND]`, state "N/A" and skip.
  - **Question 8** applies to `[LOSER]`-tagged tickers only. If not tagged `[LOSER]`, state "N/A" and skip.
  - **Question 9** applies to `[TAILWIND]`-tagged tickers only. If not tagged `[TAILWIND]`, state "N/A" and skip.

**Before applying the framework to each ticker, assess whether the earnings data is reliable enough to support P/E-based analysis.** Flag explicitly if: the company has no P/E (pre-profitability), has been profitable for fewer than 4 quarters, or has a CV high enough to suggest the earnings history is too unstable to anchor a valuation. Where data reliability is low, reduce analytical confidence accordingly and note it prominently in the Status Summary.

**Quality bar:** See the **Example Analysis** at the bottom of this prompt. It illustrates the required level of rigor, specificity, and verdict discipline — how metrics are cited to support conclusions, how the batch is held to a consistency standard across different verdict types, and how nuance (conditional passes, earnings reliability warnings, macro calibration) is surfaced within the existing framework. Do not replicate its findings mechanically; every batch presents different patterns and edge cases.

### Deliverable

**Questions:**
1. **Data Check:** Have all metrics been sourced directly from `Price_Data_{DATE}.txt` and `Earnings_{DATE}.txt` — no outside data introduced?
2. **Earnings Reliability Check:** Has the reliability of the earnings data been assessed and flagged where relevant (pre-profitability, fewer than 4 quarters of data, high CV)?
3. **Conditional Check:** Has the correct conditional logic been applied based on the stock's tags from `Peter's Digest/Screening/Screening_{DATE}.md`?
4. **Metrics Check:** Does each answer explicitly specify which metrics led to the conclusion?
5. **Summary Check:** Does the Status & Summary accurately reflect the analysis findings?
6. **Consistency Check:** Do the verdicts hold up when compared across the batch? If two tickers share similar characteristics but received different verdicts, is the difference explicitly justified?

**Output Format:**

#### {TICKER} — {Classification} ({PASS / FILTERED})

**1. How does the current price compare to historical levels?**
[Answer using specific metrics]

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
[Answer using specific metrics]

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
[Answer using specific metrics]

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
[Answer using specific metrics]

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
[Answer using specific metrics]

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
[Answer using specific metrics]

> **Pre-profitability note:** For companies with negative EPS, a positive Forward Delta means expected narrowing of losses — not expected profit. Frame it accordingly and explicitly note the company remains cash-flow negative.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
[Answer using specific metrics]

> **Anchoring warning:** A relative P/E discount (e.g., "cheaper than its historical average") does not constitute an absolute floor. Apply the rubric above based on the *absolute* P/E level only.

> **GAAP vs Adj P/E:** The data includes both a **GAAP P/E** (computed from FMP quarterly income statements — matches Google Finance) and an **Adj P/E** (non-GAAP, from FMP earnings releases). Apply the rubric above using the **GAAP P/E** as the primary valuation anchor. If the gap between GAAP and Adj is ≥15%, flag it explicitly: this signals material non-GAAP adjustments (typically SBC for software companies, or acquisition amortization). The larger the gap, the less reliable the Adj P/E is as a floor. Note: the historical P/E trend table uses Adj EPS for consistency with analyst estimates.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
[Answer using specific metrics]

> **Interpretation guidance:** A negative correlation supports an overreaction thesis — price falling while earnings rise. A positive correlation supports a rational repricing thesis — price tracking fundamental deterioration. Address the direction and strength of the correlation explicitly in the Status Summary.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
[Answer using specific metrics]

**Status & Summary**
**[PASS / FILTERED].** [A concise paragraph summarizing the findings and rationale. Include one sentence on how current market conditions from `context_markets.md` affect the confidence level of this verdict.]

- **Action:** Ask: *"Do you approve this recommendation? Should I commit this analysis to the screening file?"*

**STOP. Wait for user approval before proceeding to Step 3.**

---

## Step 3: Commit

Upon explicit user approval, update `Peter's Digest/Screening/Screening_{DATE}.md` as follows:

**Determine the target section:**
- If the ticker is present in the Candidates section of `Peter's Digest/Screening/Screening_{DATE}.md`, write to the **Screening Results** section.
- Otherwise, write to a `## Standalone` section at the bottom of the file. Create the file and/or section if they do not exist.

**For each ticker:**
1. In the Candidates section (or Standalone section), set `**Price & Earnings:**` to PASS or FILTERED.
2. In the Screening Results (or Standalone) section, append the full analysis output — all questions, answers, and Status & Summary — verbatim.
3. Set the Overall verdict.

**After all tickers in the batch are committed:**
4. Update the Status section: `Price & Earnings: Complete`.
5. Present a final summary for all tickers screened — both passed and filtered. For each, provide a brief recommendation on next steps (PIPELINE, WATCHLIST, or DROP) with one-sentence rationale. Then ask the user to decide:

```
Screening complete. Recommended next steps:

- TICKER1: PIPELINE — [rationale]
- TICKER2: WATCHLIST — [rationale]
- TICKER3: DROP — [rationale]

For each ticker you want to keep, please confirm: PIPELINE, WATCHLIST, or DROP.
Run prompt_screening_completion.md for any ticker going to PIPELINE or WATCHLIST.
```

**STOP. Wait for user decisions before proceeding.

---

## Example Analysis

The following is a completed Price & Earnings batch analysis covering six tickers. It is included to illustrate the required level of rigor, specificity, and verdict discipline — how individual metrics are cited to support conclusions, how different verdict types (PASS, CONDITIONAL PASS, FILTERED) are distinguished and justified, how earnings reliability concerns are flagged, and how the batch is held to a consistency standard. Do not replicate its findings mechanically; every batch presents different patterns and edge cases.

---

#### NOW — LOSER (PASS)

**1. How does the current price compare to historical levels?**
At $101.99, the stock is down 47% against its 1-year mark and down 26% over 2 years. It sits near the absolute bottom of its 52-week range (16% position) and offers a +55% upside if it reverts to its 1-year average.

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
The 5-year price CAGR is essentially flat at +0.4%, but this masks exceptional fundamental compounding: the 5-year EPS CAGR is +97.1%. Long-term price volatility (CV) is moderate at 0.29.

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
The stock has seen intense recent selling pressure, punctuated by an anomalous -23.6% drop in January 2026. However, the 1-year price-to-earnings correlation is -0.89, indicating that price is falling aggressively while earnings continue to rise.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
The 47% 1-year price drop is a severe anomaly when compared to the company's explosive +97.1% EPS CAGR and stable fundamental growth.

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next quarter estimate of $0.95 is slightly above the last reported actual of $0.92 (Forward Delta: +$0.03), signaling that analysts expect growth to continue smoothly despite the severe price dislocation.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
The current P/E is 29.1x, placing it in the 20–30x reasonable floor category. Notably, this represents a 63% compression from its valuation one year ago (77.8x) and is 91% below its historical average.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
The market is severely overreacting to a healthy business. The strong negative correlation (-0.89) confirms the sell-off is entirely disconnected from the company's highly stable and compounding earnings base.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**PASS.** NOW presents a textbook `[LOSER]` mispricing: a massive 47% 1-year price drop has occurred despite a +97.1% 5-year EPS CAGR and continued forward growth. The strong negative correlation (-0.89) confirms an overreaction, compressing the P/E to a reasonable 29.1x floor. In the current split-sentiment macro environment, where investors are prioritizing earnings quality and capex efficiency, NOW's highly stable and expanding earnings base provides a high-confidence reversion target. *Earnings Reliability Note:* The 5-year EPS stability CV is 0.92 — elevated relative to peers — reflecting the company's recent transition from near-zero to scaled profitability rather than genuine earnings volatility; recent quarterly EPS ($0.81, $0.82, $0.96, $0.92) confirms the current run-rate is stable. *Timing Risk:* Earnings are due 2026-04-22; the binary event adds near-term risk to any entry ahead of the print.

---

#### WDAY — LOSER (PASS)

**1. How does the current price compare to historical levels?**
At $131.11, the stock is deeply depressed, down 46% versus 1 year ago and down 47% over 5 years. It trades near the bottom of its 52-week range (13% position) with a +54% upside required to reach its 1-year average.

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
The long-term price trend is highly negative (5-year CAGR of -11.6%), yet the fundamental trend is strongly positive, with a 5-year EPS CAGR of +26.3%. Volatility is low with a CV of 0.19.

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
Price action has been brutal recently, including a -23.8% drop in February 2026. However, the 1-year correlation between price and earnings is -0.91.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
While the price drop compounds a negative 5-year trend (-11.6% CAGR), it is entirely anomalous relative to the underlying business, which has grown earnings at a +26.3% CAGR over the same period.

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next quarter estimate of $2.49 is a step up from the last reported actual of $2.47 (Forward Delta: +$0.02), indicating expectations for sustained growth.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
The current P/E is 14.2x, establishing a strong floor under 20x. This is a 58% discount to its P/E one year ago (33.6x).

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
The market is overreacting. The -0.91 correlation provides hard evidence that price has divorced entirely from a steadily growing, healthy earnings base.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**PASS.** WDAY is a high-quality software business suffering a severe dislocation. Despite a 5-year EPS CAGR of +26.3% and stable recent beats, the stock is down 46% over the last year. The resulting 14.2x P/E ratio represents a very strong valuation floor. Given the current macro scrutiny on tech/SaaS valuations, this deep multiple compression combined with an undeniably negative price-to-earnings correlation (-0.91) creates a highly defensible margin of safety.

---

#### IT — LOSER (CONDITIONAL PASS)

**1. How does the current price compare to historical levels?**
At $158.62, the stock has collapsed, down 62% over 1 year and 19% over 5 years. It sits essentially at its absolute 52-week floor (6% position).

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
The 5-year price CAGR is negative at -2.7%, while the 5-year EPS CAGR is solid at +21.9%. Price volatility is moderate (CV of 0.30).

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
The stock took a severe -25.0% hit in February 2026. The 1-year price-to-earnings correlation is +0.39, indicating that price and earnings are moving in the same direction.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
The severe 62% 1-year drop is an acceleration of a broader long-term stagnation, contrasting with its 5-year historical EPS growth.

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next quarter estimate of $2.92 represents a sharp decline from the last reported actual of $3.94, resulting in a negative Forward Delta of -$1.02. This confirms recent TTM EPS growth has turned negative (-6.3%).

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
The current P/E is 12.0x, representing a strong absolute floor (under 20x) and a 60% discount to its multiple from a year ago.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
The price decline is tracking real fundamental deterioration. The positive correlation (+0.39), combined with shrinking TTM earnings (-6.3%) and a sharp negative forward estimate delta (-$1.02), indicates the sell-off is a rational repricing of a stalling business, not an overreaction.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**CONDITIONAL PASS.** IT is a close call that does not cleanly fit either the overreaction or value trap framing. The bear case — positive correlation (+0.39), negative forward delta (-$1.02), and mild TTM EPS contraction (-6.3%) — is real but overstated: a +0.39 correlation is weak and does not confirm rational repricing the way GIS's +0.91 does. The long-term earnings record is genuinely strong: the best stability CV in this batch (0.16) and a +21.9% 5-year EPS CAGR, making 12.0x a meaningful absolute floor if the business has not structurally broken. The primary concern is the -$1.02 forward delta, though Gartner's quarterly earnings are inherently lumpy (large enterprise contract timing), and consecutive beats in prior quarters (+12.6%, +13.6%, +7.0%, +9.6%) suggest the company consistently exceeds lowered estimates. Conditional on the next quarter confirming that the estimate step-down is seasonal/timing rather than structural, the dislocation thesis is valid.

---

#### INTU — LOSER (PASS)

**1. How does the current price compare to historical levels?**
At $412.17, INTU is down 34% over the past year, though still up 3% over the 5-year horizon. It sits near its lows at a 15% 52-week position, offering a +49% reversion upside to its 1-year average.

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
The 5-year price CAGR is tepid at +2.1%, while fundamental growth has been robust, generating a +22.5% 5-year EPS CAGR.

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
The stock experienced a significant -24.5% drawdown in January 2026. The 1-year price-to-earnings correlation is heavily inverted at -0.95.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
The 34% 1-year drop is an anomaly compared to the company's steady historical price appreciation and strong, compounding earnings base.

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next estimate expects a massive seasonal jump to $12.48 from the last reported $4.15 (Forward Delta: +$8.33), highlighting intact underlying business momentum despite the stock sell-off.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
The P/E currently sits at 18.8x, establishing a strong floor under 20x. This is a 46% compression from its multiple one year ago.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
The market is deeply overreacting. The near-perfect negative correlation (-0.95) over the past year confirms that the price is falling aggressively even as TTM EPS grew +23.7%.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**PASS.** INTU is a clear `[LOSER]` pass. A 34% price drop over the past year against a +23.7% TTM EPS surge has created an extreme negative correlation (-0.95) and compressed the P/E to a highly attractive 18.8x (a strong absolute floor). The fundamental data proves the business is entirely healthy, framing this as an irrational market dislocation. Amidst current macro narratives questioning the staying power of software/SaaS, this deep value floor offers an excellent margin of safety.

---

#### KD — LOSER (FILTERED)

**1. How does the current price compare to historical levels?**
At $14.92, KD is down 54% over the last year. It is hovering near the absolute bottom of its 52-week range (14% position).

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
*Earnings Reliability Warning: KD has been profitable for fewer than 4 quarters after years of deep losses. Its stability score is extremely poor (2.12).*
The 5-year price CAGR is deeply negative at -15.0%, and price volatility is exceptionally high (CV 0.43). The 5-year EPS CAGR is not applicable due to historically negative earnings.

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
While the stock jumped 13.7% last month, it plunged 46.4% in February. The 1-year correlation is -0.88.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
The 54% 1-year drop is entirely consistent with a long-term structural decline (5-year price CAGR of -15.0%).

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next estimate is $0.43 versus the last reported $0.52, resulting in a negative Forward Delta of -$0.09.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
While the P/E is optically cheap at 8.3x (under 20x), this metric is untrustworthy given the extremely short and unstable history of profitability.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
While the correlation is negative (-0.88), suggesting the market is punishing the stock just as it crosses into profitability, the underlying business cannot be deemed "healthy" given the massive instability (2.12) and long history of losses.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**FILTERED.** KD is highly speculative. *Earnings Reliability Warning:* The company has only recently inflected to profitability after deep, multi-year losses, rendering its highly unstable earnings (2.12 stability score) and optically cheap 8.3x P/E unreliable anchors for valuation. The 54% 1-year price drop is consistent with a long-term structural decline (-15.0% 5-yr CAGR). In an environment where the market is ruthlessly demanding high-quality earnings, KD fails to provide the necessary fundamental safety margin.

---

#### NVO — LOSER (PASS)

**1. How does the current price compare to historical levels?**
At $39.03, the price is down 39% over the past year and down 68% over 2 years. It trades near the bottom of its 52-week range (9% position) and requires a +29% reversion just to reach its 1-year average.

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
The 5-year price CAGR is positive at +4.6%, supported by strong long-term fundamental growth (5-year EPS CAGR of +23.2%). Volatility is somewhat high (CV 0.41).

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
The stock was hammered in February (-37.0%) but has leveled out slightly since. The 1-year correlation between price and earnings is -0.71.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
The 39% 1-year drop is highly anomalous compared to its positive 5-year price and EPS compounding histories.

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next estimate is $0.87, representing a slight step back from the last reported $1.00 (Forward Delta: -$0.13), though previous quarters have consistently surprised to the upside.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
The P/E is 10.0x, providing a very strong floor (under 20x). This multiple is deeply compressed, down 49% YoY and 60% below its historical average.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
The market is overreacting. A negative correlation (-0.71) confirms that the aggressive price decline has occurred despite TTM earnings climbing nearly 20%.

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**PASS.** NVO is experiencing a deep price dislocation disconnected from its underlying economic reality. Despite a 5-year EPS CAGR of +23.2% and recent TTM earnings growth of +19.7%, the stock has shed 39% of its value over the past year. The negative price-earnings correlation (-0.71) confirms this as an overreaction, yielding an incredibly cheap 10.0x P/E floor. In the current macro climate, finding robust, historically stable growth at a 10.0x absolute multiple provides a premier margin of safety.

---

#### GIS — LOSER (FILTERED)

**1. How does the current price compare to historical levels?**
At $35.10, the stock is down 35% over the past year and down 55% over 3 years. It is essentially at its 52-week low (5% position).

**2. What are the long-term price and earnings trends and volatility? (past 5 years)**
Both long-term trends are negative. The 5-year price CAGR is -6.8% and the 5-year EPS CAGR is -3.4%. Price volatility is low (CV 0.16).

**3. What are the short-term price and earnings trends and volatility? (past 12 months)**
The stock saw a heavy -17.7% drop in March 2026. Crucially, the 1-year correlation between price and earnings is +0.91.

**4. `[LOSER]` Is the current price drop an anomaly or consistent with the long-term trend?**
The 35% drop is entirely consistent with the 5-year negative trend in both price (-6.8% CAGR) and fundamentals (-3.4% EPS CAGR).

**5. `[TAILWIND]` Is the stock trading near the top of its 52-week range or has it surged significantly in recent months, suggesting the tailwind may already be priced in?**
N/A

**6. How do the upcoming earnings estimates compare to the company's past performance, and what does this signal about near-term analyst sentiment?**
The next estimate of $0.83 is a moderate bounce off a weak previous quarter ($0.64), resulting in a Forward Delta of +$0.19. However, TTM EPS is down 25.4% YoY.

**7. Is the current P/E under 20x (strong floor), 20–30x (reasonable floor), or over 30x (caution — no meaningful floor)?**
The P/E is 10.5x, establishing a strong floor under 20x in absolute terms.

**8. `[LOSER]` Is the price decline tracking real fundamental deterioration, or is the market overreacting to a healthy business?**
The price decline is rationally tracking severe fundamental deterioration. The near-perfect positive correlation (+0.91) demonstrates that the stock is falling directly in tandem with a collapsing earnings base (-25.4% TTM EPS).

**9. `[TAILWIND]` Does what the company is currently earning justify the current price — and if not, does the earnings trend suggest it will?**
N/A

**Status & Summary**
**FILTERED.** GIS is the textbook definition of a rational repricing rather than an overreaction. While the P/E looks cheap at 10.5x, the near-perfect positive correlation (+0.91) proves that the price drop is entirely justified by a shrinking underlying business (TTM EPS down 25.4%, 5-year EPS CAGR of -3.4%). A low P/E provides no margin of safety if the earnings it is anchored to are continually degrading. This is a value trap.**
